Therapy of chemotherapy‐induced peripheral neuropathy

No abstract is available for this paper.

• Publication year

  2009

• Venue

  British Journal of Haematology

• Publication date

  2009-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.2008.07558.xPMID 19170681
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms.

  2008cited by this paper
• Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy

  2008cited by this paper
• A review on oxaliplatin-induced peripheral nerve damage.

  2008cited by this paper
• Elevated B6 levels and peripheral neuropathies.

  2008cited by this paper
• Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity

  2008cited by this paper
• Targeting cancer and neuropathy with histone deacetylase inhibitors: two birds with one stone?

  2008cited by this paper
• Chemotherapy‐evoked neuropathic pain: Abnormal spontaneous discharge in A‐fiber and C‐fiber primary afferent neurons and its suppression by acetyl‐l‐carnitine

  2008cited by this paper
• Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy

  2007cited by this paper
• Peripheral neuropathy related to chemotherapy.

  2007cited by this paper
• Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity.

  2007influential reference
• Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain.

  2007cited by this paper
• Neurologic complications of chemotherapy agents

  2007cited by this paper
• Neuroprotection During Chemotherapy: A Systematic Review

  2007cited by this paper
• Neuropathy in multiple myeloma treated with thalidomide

  2007cited by this paper
• Treatment of painful neuropathy

  2007cited by this paper
• Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain.

  2007cited by this paper
• Acupuncture Treatment for Chemotherapy-Induced Peripheral Neuropathy – a Case Series

  2006cited by this paper
• Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation.

  2006cited by this paper
• A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results

  2006cited by this paper
• Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy

  2006cited by this paper
• Neurological complications of cancer chemotherapy

  2006cited by this paper
• Phase I trial of first-line bortezomib/thalidomide plus chemotherapy for induction and stem cell mobilization in patients with multiple myeloma.

  2006cited by this paper
• Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy.

  2006cited by this paper
• Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib.

  2006cited by this paper
• N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data

  2006cited by this paper
• Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study

  2006cited by this paper
• Prevention of Chemotherapy-Induced Neuropathy: Leukemia Inhibitory Factor

  2005cited by this paper
• Frequency, Characteristics, and Reversibility of Peripheral Neuropathy (PN) in the APEX Trial.

  2005cited by this paper
• Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine.

  2005cited by this paper
• A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy

  2005cited by this paper
• Corrigendum to “Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study” [Pain 110 (2004) 697–706]

  2005cited by this paper
• A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy

  2005cited by this paper
• Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy.

  2005cited by this paper
• Gabapentin is Effective in the Treatment of Cancer-Related Neuropathic Pain: A Prospective, Open-Label Studya,b

  2005cited by this paper
• Vitamin E for prophylaxis against chemotherapy-induced neuropathy

  2005cited by this paper
• Prevention of chemotherapy-induced neuropathy: leukemia inhibitory factor.

  2005cited by this paper
• Painful peripheral neuropathy and its nonsurgical treatment

  2004cited by this paper
• Spinal cord stimulation relieves chemotherapy-induced pain: a clinical case report.

  2004cited by this paper
• Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double‐blind, placebo‐controlled study

  2004cited by this paper
• Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study.

  2004cited by this paper
• Topiramate vs placebo in painful diabetic neuropathy

  2004cited by this paper
• Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double‐blind, placebo‐controlled trial

  2004cited by this paper
• Antiepileptic drugs: indications other than epilepsy.

  2004cited by this paper
• Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies

  2004cited by this paper
• Levetiracetam in the Treatment of Neuropathic Pain: Three Case Studies

  2004cited by this paper
• Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group.

  2004cited by this paper
• Chemotherapy-induced neuropathy: treatment by decompression of peripheral nerves.

  2004cited by this paper
• Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions

  2004cited by this paper
• Amelioration of docetaxel/cisplatin induced polyneuropathy by α-lipoic acid

  2003cited by this paper
• Off-label applications for SSRIs.

  2003cited by this paper
• Controlled‐release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

  2003cited by this paper
• Trends in opioid use for chronic neuropathic pain: a survey of patients pursuing enrollment in clinical trials.

  2003cited by this paper
• Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy.

  2003cited by this paper
• Amelioration of docetaxel/cisplatin induced polyneuropathy by alpha-lipoic acid.

  2003cited by this paper
• Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine.

  2003cited by this paper
• Botanicals and dietary supplements in diabetic peripheral neuropathy.

  2003cited by this paper
• Rationale and evidence for the use of oxcarbazepine in neuropathic pain.

  2003cited by this paper
• Neurologic Complications of Cancer

  2003cited by this paper
• Prevention of chemotherapy and radiation toxicity with glutamine.

  2003cited by this paper
• Trends in opioid use for chronic neuropathic pain: a survey of patients pursuing enrollment in clinical trials

  2003cited by this paper
• Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a phase II study of the Gynecologic Oncology Group.

  2003cited by this paper
• Protection against oxaliplatin acute neurosensory toxicity by venlafaxine

  2003cited by this paper
• Phase III evaluation of nortriptyline for alleviation of symptoms of cis‐platinum‐induced peripheral neuropathy

  2002cited by this paper
• Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid.

  2002cited by this paper
• Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial.

  2002cited by this paper
• Reduction of paclitaxel-induced peripheral neuropathy with glutamine.

  2001influential reference
• Lamotrigine reduces painful diabetic neuropathy

  2001cited by this paper
• A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy

  2000cited by this paper
• Grading of chemotherapy-induced peripheral neuropathy.

  2000cited by this paper
• Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor.

  2000cited by this paper
• Cisplatin‐Induced Apoptotic Cell Death in Mouse Hybrid Neurons Is Blocked by Antioxidants Through Suppression of Cisplatin‐Mediated Accumulation of p53 but Not of Fas/Fas Ligand

  2000cited by this paper
• Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review.

  2000cited by this paper
• Gabapentin Enhances the Analgesic Effect of Morphine in Healthy Volunteers

  2000cited by this paper
• 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial.

  1999cited by this paper
• Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial

  1999cited by this paper
• Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.

  1999cited by this paper
• Chemotherapeutic neuropathy.

  1999cited by this paper
• Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

  1998cited by this paper
• Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy

  1998cited by this paper
• Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing

  1997cited by this paper
• Neurologic Complications of Cancer.

  1996cited by this paper
• Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.

  1996cited by this paper
• Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial.

  1995cited by this paper
• Double‐blind, placebo‐controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy

  1995cited by this paper
• Evolution of neuropathy and myopathy during intensive vincristine/corticosteroid chemotherapy for non‐hodgkin's lymphoma

  1991cited by this paper
• Cisplatin neuropathy. Risk factors, prognosis, and protection by WR‐2721

  1988cited by this paper
• Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy.

  1987cited by this paper

• Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian cancer: a phase 3, double-blind, parallel group, randomized controlled pilot study

  2026cites this paper
• The effect of oral curcumin on vincristine-induced neuropathy in pediatric acute lymphoblastic leukemia: A double-blind randomized controlled clinical trial

  2025cites this paper
• A systematic review of steroid use in peripheral nerve pathologies and treatment

  2024cites this paper
• The effect of hand-foot exercises on chemotherapy-induced peripheral neuropathy-related pain, falls, and quality of life in colorectal cancer: A randomized controlled trial.

  2024cites this paper
• Effectiveness of an intervention (effleurage and petrissage) on the severity of chemotherapy-induced peripheral neuropathy (CIPN) among patients: A randomized control pilot trial.

  2024cites this paper
• In Vitro Models for Neuropathic Pain Phenotypic Screening in Brain Therapeutics.

  2024cites this paper
• Chemotherapy-induced peripheral neuropathy according to biopsychosocial model: A descriptive cross-sectional correlational study

  2024cites this paper
• Wellbeing and Complementary Therapies in Breast Cancer Peripheral Neuropathy Care: A Scoping Review Focused on Foot Health

  2023cites this paper
• Ozone in Chemotherapy-Induced Peripheral Neuropathy—Current State of Art, Possibilities, and Perspectives

  2023cites this paper
• Evaluation of 8% Capsaicin Patches in Chemotherapy-Induced Peripheral Neuropathy: A Retrospective Study in a Comprehensive Cancer Center

  2023cites this paper
• Milnacipran Has an Antihyperalgesic Effect on Cisplatin-Induced Neuropathy

  2023cites this paper
• Efficacy of a rehabilitation program using minor muscles in colorectal cancer patients with chemotherapy-induced neuropathy: preliminary study

  2022cites this paper
• Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update

  2022cites this paper
• The Ameliorative Effect of Thymoquinone on Vincristine-Induced Peripheral Neuropathy in Mice by Modulating Cellular Oxidative Stress and Cytokine

  2022influential citation
• Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR Axis

  2022cites this paper
• Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: study protocol for a phase III, double-blind, randomized study

  2021cites this paper
• Effects of Curcumin and Its Different Formulations in Preclinical and Clinical Studies of Peripheral Neuropathic and Postoperative Pain: A Comprehensive Review

  2021cites this paper
• Physical Medicine and Rehabilitation.

  2021cites this paper
• Clinical and biochemical markers in CIPN: A reappraisal.

  2021cites this paper
• Development of a novel in vitro assay to screen for neuroprotective drugs against iatrogenic neurite shortening

  2021cites this paper
• Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy

  2021cites this paper
• Neurologic Complications of Chemotherapy and Radiation Therapy

  2021cites this paper
• Exploring the Possible Mechanism and Drug Targets of Huang-Qi-Gui-Zhi-Wu-Wu Decoction for the Treatment of Chemotherapy-Induced Peripheral Neuropathy on Network Pharmacology

  2020cites this paper
• Efficacy of Alpha Lipoic Acid Supplementation In Chemotherapy-Induced Peripheral Neuropathy

  2020cites this paper
• Gabapentin and Duloxetine Prevent Oxaliplatin- and Paclitaxel-Induced Peripheral Neuropathy by Inhibiting Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Phosphorylation in Spinal Cords of Mice

  2020cites this paper
• Chemotherapy-induced Peripheral Neuropathy in Patients with Breast Cancer: Associated Factors and Impact on Health-Related Quality of Life

  2020cites this paper
• Chemotherapy Induced Peripheral Neuropathy – A Review

  2020cites this paper
• Behavioral, Histopathologic, and Molecular Biological Responses of Nanoparticle- and Solution-Based Formulations of Vincristine in Mice

  2020cites this paper
• Vincristine-induced peripheral neuropathy: a mini-review.

  2020cites this paper
• Chemotherapy-Induced Peripheral Neuropathy

  2020cites this paper
• Chemotherapy-Induced Peripheral Neuropathy

  2020cites this paper
• Neurotoxicity of antineoplastic drugs: Mechanisms, susceptibility, and neuroprotective strategies.

  2020cites this paper
• Low Intensity Focused Ultrasound Modulation of Vincristine Induced Neuropathy.

  2020cites this paper
• Prevention of paclitaxel-induced neuropathy by formulation approach.

  2019influential citation
• The effect of analgesics on stimulus evoked pain-like behaviour in animal models for chemotherapy induced peripheral neuropathy- a meta-analysis

  2019cites this paper
• Metformin reduces c-Fos and ATF3 expression in the dorsal root ganglia and protects against oxaliplatin-induced peripheral sensory neuropathy in mice.

  2019cites this paper
• Impact of Somatic Yoga and Meditation on Fall Risk, Function, and Quality of Life for Chemotherapy-Induced Peripheral Neuropathy Syndrome in Cancer Survivors

  2019cites this paper
• Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy

  2019cites this paper
• related to in patients treatment with

  2019cites this paper
• ASSESSMENT OF THE ROLE OF ALPHALIPOIC ACID IN PREVENTION OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY.

  2019cites this paper
• Ocular surface adverse events of systemic epidermal growth factor receptor inhibitors (EGFRi): A prospective trial.

  2018cites this paper
• Inhibition of spinal 15-LOX-1 attenuates TLR4-dependent, nonsteroidal anti-inflammatory drug–unresponsive hyperalgesia in male rats

  2018cites this paper
• Effect of Vitis vinifera hydroalcoholic extract against oxaliplatin neurotoxicity: in vitro and in vivo evidence

  2018cites this paper
• Optical examination of the efficacy of contact needle therapy for chemotherapy-induced peripheral neuropathy: integration of inspection in Kampo therapy with color spectrum information

  2018cites this paper
• The quality of guidelines in non-pharmacological prevention and management of chemotherapy-induced neuropathy: A review

  2018cites this paper
• Electroacupuncture alleviates chemotherapy‐induced pain through inhibiting phosphorylation of spinal CaMKII in rats

  2018cites this paper
• Scrambler therapy efficacy and safety for neuropathic pain correlated with chemotherapy‐induced peripheral neuropathy in adolescents: A preliminary study

  2018cites this paper
• Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: a randomized controlled trial

  2018cites this paper
• A novel endpoint for the assessment of chemotherapy‐induced peripheral neuropathy in rodents: biomechanical properties of peripheral nerve

  2018cites this paper
• High-Intensity Ultrasound Treatment for Vincristine-Induced Neuropathic Pain

  2018cites this paper
• Vinca alkaloid-induced peripheral neuropathy in Zaria, North Western Nigeria: A case report

  2018influential citation
• The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP

  2018cites this paper
• Neuropathy and neural plasticity in the subcutaneous white adipose depot

  2018cites this paper
• Inhibition of Spinal 15-LOX-1 Attenuates TLR4-Dependent, NSAID-Unresponsive Hyperalgesia in Male Rats.

  2018cites this paper
• Gabapentin and its salicylaldehyde derivative alleviate allodynia and hypoalgesia in a cisplatin‐induced neuropathic pain model

  2017cites this paper
• Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review

  2017cites this paper
• Treatment Recommendations of a Rare Neurological Paraneoplastic Syndrome Caused by Small Cell Lung Cancer: A Case Report

  2017cites this paper
• Vincristine‐induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: Frequent autonomic and more severe cranial nerve involvement

  2017cites this paper
• Clinical effectiveness of low-level laser treatment on peripheral somatosensory neuropathy

  2017cites this paper
• Cellular mechanisms of cyclophosphamide-induced taste loss in mice

  2017cites this paper
• Laser acupuncture treatment of neuropathic pain in a boy with brain tumour.

  2017cites this paper
• The flavonoid 6-methoxyflavone allays cisplatin-induced neuropathic allodynia and hypoalgesia.

  2017cites this paper
• Quetiapine reverses paclitaxel-induced neuropathic pain in mice: Role of alpha2- adrenergic receptors

  2017cites this paper
• Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy

  2017cites this paper
• The Relationship Between Total Neuropathy Score-reduced, Neuropathy Symptoms and Function.

  2017cites this paper
• Efficacy of Japanese traditional (Kampo) medicine for treating chemotherapy-induced peripheral neuropathy: A retrospective case series study

  2016cites this paper
• The Role of Exercise in Chemotherapy-Induced Peripheral Neuropathy

  2016cites this paper
• The Efficacy of Percutaneous Auricular Neurostimulation for Chemotherapy-Induced Peripheral Neuropathy: A Retrospective Chart Review

  2016cites this paper
• A Systematic Review on Neuropathy

  2016cites this paper
• Chemotherapy-Induced Peripheral Neuropathy.

  2016cites this paper
• Maerua angolensis Extract Reduces Allodynia and Hyperalgesia in a Mouse Model of Vincristine-Induced Peripheral Neuropathy -

  2016cites this paper
• Synthesis and T-type calcium channel-blocking effects of aryl(1,5-disubstituted-pyrazol-3-yl)methyl sulfonamides for neuropathic pain treatment.

  2016cites this paper
• The Interdisciplinary Rehabilitation Care Team and the Role of Physical Therapy in Survivor Exercise.

  2016cites this paper
• The effect of thioctic acid on allodynia in a rat vincristine-induced neuropathy model

  2015cites this paper
• Assessment of chemotherapy-induced peripheral neuropathy using the LDIFLARE technique: a novel technique to detect neural small fiber dysfunction

  2015cites this paper
• Quality of life and resilience related to chemotherapy-induced peripheral neuropathy in patients post treatment with platinums and taxanes

  2015cites this paper
• Effect of curcumin in mice model of vincristine-induced neuropathy

  2015cites this paper
• [Chemotherapy-induced Peripheral Neuropathy].

  2015cites this paper
• Antineuropathic Profile of N-Palmitoylethanolamine in a Rat Model of Oxaliplatin-Induced Neurotoxicity

  2015cites this paper
• Neurologic Complications of Chemotherapy and Radiation Therapy

  2015cites this paper
• Durch Bewegungsinterventionen Symptome reduzieren

  2015cites this paper
• Neurotoxic 1‐deoxysphingolipids and paclitaxel‐induced peripheral neuropathy

  2015cites this paper
• Addressing the needs of colorectal cancer survivors: current strategies and future directions

  2015cites this paper
• Assessment and Treatment of Chemotherapy-induced Peripheral Neuropathy- a Physical Therapy Perspective

  2015cites this paper
• The Effect of Supervised Exercise Training on Symptoms of Chemotherapy- Induced Peripheral Neuropathy

  2014cites this paper
• Behavioral pharmacology of pain.

  2014cites this paper
• Treatment of Multiple Myeloma: Thalidomide-, Bortezomib-, and Lenalidomide-Induced Peripheral Neuropathy

  2014cites this paper
• Inflammation: Therapeutic Targets for Diabetic Neuropathy

  2014cites this paper
• Involvement of α7 nAChR subtype in rat oxaliplatin-induced neuropathy: effects of selective activation.

  2014cites this paper
• Exercise Intervention Studies in Patients with Peripheral Neuropathy: A Systematic Review

  2014cites this paper
• Neuropathic cancer pain: What we are dealing with? How to manage it?

  2014cites this paper
• Glial role in oxaliplatin-induced neuropathic pain.

  2014cites this paper
• Novel TRPM8 Antagonist Attenuates Cold Hypersensitivity after Peripheral Nerve Injury in Rats

  2014cites this paper
• Effect of Histone Deacetylase Inhibitor JNJ-26481585 in Pain

  2014cites this paper
• Ameliorative effect of Vernonia cinerea in vincristine-induced painful neuropathy in rats

  2014cites this paper
• Oxaliplatin-induced neuropathy in colorectal cancer: many questions with few answers.

  2014cites this paper
• Occupational exposure to municipal solid wastes and development of toxic neuropathies: Possible role of nutrient supplementation, complementary and alternative medicines in chemoprevention

  2014cites this paper
• Optimization and pharmacological characterization of a refined cisplatin-induced rat model of peripheral neuropathic pain

  2014cites this paper
• Antinociceptive effect of matrine on vincristine-induced neuropathic pain model in mice

  2014cites this paper
• Neurochemical characterization of primary sensory neurons in a rat model of bortezomic-induced peripheral neuropathy

  2014cites this paper